Company Filing History:
3 out of 590 
2 out of 601 
Years Active: 2014-2017
Title: Preethi Gunaratne: Innovating Cancer Treatments through MicroRNA Research
Introduction
Preethi Gunaratne is a notable inventor based in Houston, TX, who has significantly contributed to the field of cancer treatment through his innovative work in microRNA research. With a total of three patents to his name, his inventions have the potential to transform therapeutic approaches to various forms of cancer.
Latest Patents
Gunaratne’s latest patents focus on the pivotal role of microRNAs in enhancing chemotherapy effectiveness. One such patent, titled “miR-520 microRNAs sensitize cancers to platinum-based therapy,” revolves around methods and compositions that involve microRNAs, including miR-520a, miR-520g, and miR-520h. This invention specifically targets ovarian cancer and seeks to improve patient response to platinum-based chemotherapy.
Another significant patent, “MicroRNA-130a,b as a tumor suppressor and sensitizing agent for chemotherapy,” outlines methods to improve therapeutic responses to cancer treatments. This patent describes administering an agent that enhances the expression of microRNA-130, thereby providing an innovative way to treat subjects in need of cancer therapy.
Career Highlights
Preethi Gunaratne has had a distinguished career, with impactful roles at reputable institutions such as the University of Houston System and Baylor College of Medicine. His research has laid the groundwork for advanced therapeutic strategies in oncology, particularly targeting microRNA capabilities in cancer sensitization.
Collaborations
Throughout his career, Gunaratne has collaborated with remarkable individuals, including Matthew L. Anderson and Claire Mach. These partnerships have significantly contributed to the advancement of cancer research and the development of innovative treatments.
Conclusion
In summary, Preethi Gunaratne is a pioneering inventor whose work in microRNA research holds great promise for improving cancer treatment outcomes. His patents reflect not only his innovative spirit but also his commitment to addressing critical challenges in medical therapy, benefiting countless patients in the fight against cancer.